{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:14:03Z","timestamp":1784927643081,"version":"3.55.0"},"reference-count":163,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Higher Education of the Russian Federation","award":["075-15-2021-1355"],"award-info":[{"award-number":["075-15-2021-1355"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibodies"],"abstract":"<jats:p>The rapid rise in monkeypox virus infections among humans from 2022 to 2024 has captured the attention of the global healthcare community. In light of the lack of mandatory vaccination and limited data on next-generation vaccines for monkeypox prevention, the urgent development of therapeutic agents has become a priority. One promising approach involves the use of neutralizing monoclonal antibodies. This review highlights significant advancements in the search for antibodies against human pathogenic orthopoxviruses, particularly focusing on their potential application against the monkeypox virus. We also analyze viral proteins that serve as targets for identifying therapeutic antibodies capable of neutralizing a wide range of viruses. Finally, we deemed it essential to address the challenges associated with selecting an animal model that can adequately reflect the infectious process of each orthopoxvirus species in humans.<\/jats:p>","DOI":"10.3390\/antib14010020","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T04:46:37Z","timestamp":1740545197000},"page":"20","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Monoclonal Antibodies in Light of Mpox Outbreak: Current Research, Therapeutic Targets, and Animal Models"],"prefix":"10.3390","volume":"14","author":[{"given":"Vladimir N.","family":"Nikitin","sequence":"first","affiliation":[{"name":"State Research Center of Virology and Biotechnology Vector, Rospotrebnadzor, Koltsovo 630559, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6974-0686","authenticated-orcid":false,"given":"Iuliia A.","family":"Merkuleva","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology Vector, Rospotrebnadzor, Koltsovo 630559, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8023-4453","authenticated-orcid":false,"given":"Dmitriy N.","family":"Shcherbakov","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology Vector, Rospotrebnadzor, Koltsovo 630559, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"MacNeill, A.L. (2022). Comparative Pathology of Zoonotic Orthopoxviruses. Pathogens, 11.","DOI":"10.3390\/pathogens11080892"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/505880","article-title":"Clinical Manifestations of Human Monkeypox Influenced by Route of Infection","volume":"194","author":"Reynolds","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"E30406","DOI":"10.1097\/MD.0000000000030406","article-title":"Human Monkeypox Virus: An Updated Review","volume":"101","author":"Adnan","year":"2022","journal-title":"Medicine"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Silva, N.I.O., de Oliveira, J.S., Kroon, E.G., Trindade, G.d.S., and Drumond, B.P. (2020). Here, There, and Everywhere: The Wide Host Range and Geographic Distribution of Zoonotic Orthopoxviruses. Viruses, 13.","DOI":"10.3390\/v13010043"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Alakunle, E., Moens, U., Nchinda, G., and Okeke, M.I. (2020). Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution. Viruses, 12.","DOI":"10.3390\/v12111257"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3201\/eid1404.071044","article-title":"Retrospective Analysis of Monkeypox Infection","volume":"14","author":"Dubois","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/s41564-020-0706-0","article-title":"Monkeypox Virus Emergence in Wild Chimpanzees Reveals Distinct Clinical Outcomes and Viral Diversity","volume":"5","author":"Patrono","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3201\/eid2009.140154","article-title":"Spread of Vaccinia Virus to Cattle Herds, Argentina, 2011","volume":"20","author":"Costa","year":"2014","journal-title":"Emerg. Infect Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijid.2018.11.008","article-title":"Monkeypox\u2014Enhancing Public Health Preparedness for an Emerging Lethal Human Zoonotic Epidemic Threat in the Wake of the Smallpox Post-Eradication Era","volume":"78","author":"Petersen","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"ref_10","first-page":"593","article-title":"A Human Infection Caused by Monkeypox Virus in Basankusu Territory, Democratic Republic of the Congo","volume":"46","author":"Ladnyj","year":"1972","journal-title":"Bull. World Health Organ."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Sklenovsk\u00e1, N., and van Ranst, M. (2018). Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans. Front. Public Health, 6.","DOI":"10.3389\/fpubh.2018.00241"},{"key":"ref_12","unstructured":"(2024, June 29). Multi-Country Outbreak of Mpox (Monkeypox)\u2014External Situation Report 33, Published 31 May 2024\u2014World|ReliefWeb. 13 Cite 97000 Cases. Available online: https:\/\/reliefweb.int\/report\/world\/multi-country-outbreak-mpox-monkeypox-external-situation-report-33-published-31-may-2024."},{"key":"ref_13","unstructured":"European Centre for Disease Prevention and Control (2024). Risk Assessment for the EU\/EEA of the Mpox Epidemic Caused by Monkeypox Virus Clade I in Affected African Countries, European Centre for Disease Prevention and Control."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bunge, E.M., Hoet, B., Chen, L., Lienert, F., Weidenthaler, H., Baer, L.R., and Steffen, R. (2022). The Changing Epidemiology of Human Monkeypox\u2014A Potential Threat? A Systematic Review. PLoS Negl. Trop. Dis., 16.","DOI":"10.1371\/journal.pntd.0010141"},{"key":"ref_15","unstructured":"(2023, February 17). Weekly Bulletin on Outbreak and Other Emergencies: Week 52: 19 to 25 December 2022. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/365480."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.medmal.2018.02.010","article-title":"Investigation of an Outbreak of Monkeypox in an Area Occupied by Armed Groups, Central African Republic","volume":"48","author":"Kalthan","year":"2018","journal-title":"Med. Mal. Infect."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S1473-3099(19)30294-4","article-title":"Outbreak of Human Monkeypox in Nigeria in 2017-18: A Clinical and Epidemiological Report","volume":"19","author":"Aruna","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Vaughan, A., Aarons, E., Astbury, J., Balasegaram, S., Beadsworth, M., Beck, C.R., Chand, M., O\u2019connor, C., Dunning, J., and Ghebrehewet, S. (2018). Two Cases of Monkeypox Imported to the United Kingdom, September 2018. Eurosurveillance, 23.","DOI":"10.2807\/1560-7917.ES.2018.23.38.1800509"},{"key":"ref_19","unstructured":"(2022, August 16). FDA Found More Than Smallpox Vials in Storage Room\u2014The Washington Post. Available online: https:\/\/www.washingtonpost.com\/national\/health-science\/fda-found-more-than-smallpox-vials-in-storage-room\/2014\/07\/16\/850d4b12-0d22-11e4-8341-b8072b1e7348_story.html."},{"key":"ref_20","unstructured":"(2022, August 16). Philadelphia Lab Briefly Locked Down After Worker Finds \u2018Smallpox\u2019 Vials in Freezer|Vaccines and Immunisation|The Guardian. Available online: https:\/\/www.theguardian.com\/society\/2021\/nov\/18\/philadelphia-lab-smallpox-vials-freezer."},{"key":"ref_21","unstructured":"(2022, August 16). CDC Approves Partial Resumption of USAMRIID Select Agent Research\u2014Global Biodefense. Available online: https:\/\/globalbiodefense.com\/2019\/11\/23\/cdc-approves-partial-resumption-of-usamriid-select-agent-research\/."},{"key":"ref_22","unstructured":"(2022, August 16). Report to the Commissioner: FDAReview of the 2014 Discovery of Vials Labeled, \u201c.V.a.r.i.o.l.a.\u201d.; Other Vials Discovered in an FDA-Occupied Building on the NIHCampus, F.D.A, Available online: https:\/\/www.fda.gov\/about-fda\/reports\/report-commissioner-fda-review-2014-discovery-vials-labeled-variola-and-other-vials-discovered-fda."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e271","DOI":"10.1111\/ijd.17218","article-title":"Understanding Borealpox virus: An update for clinicians following the first mortality","volume":"63","author":"Bishnoi","year":"2024","journal-title":"Int. J. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Babkin, I.V., Babkina, I.N., and Tikunova, N.V. (2022). An Update of Orthopoxvirus Molecular Evolution. Viruses, 14.","DOI":"10.3390\/v14020388"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2340\/00015555-1227","article-title":"The Munich outbreak of cutaneous cowpox infection: Transmission by infected pet rats","volume":"92","author":"Vogel","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.3201\/eid1912.130256","article-title":"Concomitant Human Infections with 2 Cowpox Virus Strains in Related Cases, France, 2011","volume":"19","author":"Ducournau","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00467-016-3534-y","article-title":"Fatal disseminated cowpox virus infection in an adolescent renal transplant recipient","volume":"32","author":"Gazzani","year":"2017","journal-title":"Pediatr. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0140-6736(17)31428-9","article-title":"Generalised cowpox virus infection","volume":"390","author":"Baltzer","year":"2017","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijid.2020.12.061","article-title":"Cowpox: How dangerous could it be for humans? Case report","volume":"104","author":"Krankowska","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1111\/bjd.19319","article-title":"A case of cowpox virus infection in the UK occurring in a domestic cat and transmitted to the adult male owner","volume":"183","author":"Haddadeen","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/cid\/ciy388","article-title":"Skin Lesions in a Child After Contact With a Domestic Rat","volume":"68","author":"Nardin","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1017\/S0950268816002922","article-title":"Cowpox in a human, Russia, 2015","volume":"145","author":"Popova","year":"2017","journal-title":"Epidemiol. Infect."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Eder, I., Vollmar, P., Pfeffer, M., Naether, P., Rodloff, A.C., and Meyer, H. (2017). Two Distinct Clinical Courses of Human Cowpox, Germany, 2015. Viruses, 9.","DOI":"10.3390\/v9120375"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijid.2021.03.076","article-title":"Generalized cowpox virus infection in an immunosuppressed patient","volume":"106","author":"Wendt","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Oliveira, J., Figueiredo, P., Costa, G., Assis, F., Drumond, B., da Fonseca, F., Nogueira, M., Kroon, E., and Trindade, G. (2017). Vaccinia Virus Natural Infections in Brazil: The Good, the Bad, and the Ugly. Viruses, 9.","DOI":"10.3390\/v9110340"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13337-012-0068-1","article-title":"Emergence and Reemergence of Vaccinia-Like Viruses: Global Scenario and Perspectives","volume":"23","author":"Singh","year":"2012","journal-title":"Indian J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Eltom, K.H., Samy, A.M., Abd El Wahed, A., and Czerny, C.-P. (2020). Buffalopox Virus: An Emerging Virus in Livestock and Humans. Pathogens, 9.","DOI":"10.3390\/pathogens9090676"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Lima, M.T., Oliveira, G.P., Afonso, J.A.B., Souto, R.J.C., de Mendon\u00e7a, C.L., Dantas, A.F.M., Abrahao, J.S., and Kroon, E.G. (2018). An Update on the Known Host Range of the Brazilian Vaccinia Virus: An Outbreak in Buffalo Calves. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.03327"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3201\/eid2506.171306","article-title":"Outbreak of Vaccinia Virus Infection from Occupational Exposure, China, 2017","volume":"25","author":"Lu","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3201\/eid2104.140351","article-title":"Outbreak of severe zoonotic vaccinia virus infection, Southeastern Brazil","volume":"21","author":"Campos","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/infdis\/jir527","article-title":"Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults","volume":"204","author":"Kennedy","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.vaccine.2022.10.056","article-title":"A randomized phase 3 trial to assess the immunogenicity and safety of 3 consecutively produced lots of freeze-dried MVA-BN\u00ae vaccine in healthy adults","volume":"41","author":"Overton","year":"2023","journal-title":"Vaccine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1128\/JVI.02797-14","article-title":"Evolution of and Evolutionary Relationships between Extant Vaccinia Virus Strains","volume":"89","author":"Qin","year":"2015","journal-title":"J. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Smithson, C., Purdy, A., Verster, A.J., and Upton, C. (2014). Prediction of Steps in the Evolution of Variola Virus Host Range. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091520"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"524743","DOI":"10.1155\/2012\/524743","article-title":"Orthopoxvirus Genes That Mediate Disease Virulence and Host Tropism","volume":"2012","author":"Shchelkunov","year":"2012","journal-title":"Adv. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.meegid.2012.12.002","article-title":"A survey of host range genes in poxvirus genomes","volume":"14","author":"Bratke","year":"2013","journal-title":"Infect. Genet. Evol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-virology-091919-104752","article-title":"The Life Cycle of the Vaccinia Virus Genome","volume":"9","author":"Greseth","year":"2022","journal-title":"Annu. Rev. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Moss, B. (2013). Poxvirus DNA Replication. Cold Spring Harb. Perspect. Biol., 5.","DOI":"10.1101\/cshperspect.a010199"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9899","DOI":"10.1128\/JVI.05446-11","article-title":"Expression Profiling of the Intermediate and Late Stages of Poxvirus Replication","volume":"85","author":"Yang","year":"2011","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.virol.2012.08.044","article-title":"Orthopoxvirus species and strain differences in cell entry","volume":"433","author":"Bengali","year":"2012","journal-title":"Virology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semcdb.2016.07.015","article-title":"Membrane fusion during poxvirus entry","volume":"60","author":"Moss","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"17517","DOI":"10.1073\/pnas.0909376106","article-title":"Appraising the apoptotic mimicry model and the role of phospholipids for poxvirus entry","volume":"106","author":"Laliberte","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41564-019-0488-4","article-title":"Nanoscale polarization of the entry fusion complex of vaccinia virus drives efficient fusion","volume":"4","author":"Gray","year":"2019","journal-title":"Nat. Microbiol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Laliberte, J.P., Weisberg, A.S., and Moss, B. (2011). The Membrane Fusion Step of Vaccinia Virus Entry Is Cooperatively Mediated by Multiple Viral Proteins and Host Cell Components. PLoS Pathog., 7.","DOI":"10.1371\/journal.ppat.1002446"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1038\/emboj.2011.245","article-title":"Vaccinia extracellular virions enter cells by macropinocytosis and acid-activated membrane rupture","volume":"30","author":"Schmidt","year":"2011","journal-title":"EMBO J."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Hernandez-Gonzalez, M., Calcraft, T., Nans, A., Rosenthal, P.B., and Way, M. (2023). A succession of two viral lattices drives vaccinia virus assembly. PLoS Biol., 21.","DOI":"10.1371\/journal.pbio.3002005"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.chom.2009.05.021","article-title":"Membrane rupture generates single open membrane sheets during vaccinia virus assembly","volume":"6","author":"Chlanda","year":"2009","journal-title":"Cell Host Microbe"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virusres.2014.01.016","article-title":"Novel insights on the progression of intermediate viral forms in the morphogenesis of vaccinia virus","volume":"183","author":"Cepeda","year":"2014","journal-title":"Virus Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"12313","DOI":"10.1128\/JVI.02137-13","article-title":"Direct Formation of Vaccinia Virus Membranes from the Endoplasmic Reticulum in the Absence of the Newly Characterized L2-Interacting Protein A30.5","volume":"87","author":"Weisberg","year":"2013","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.virol.2015.02.003","article-title":"Poxvirus membrane biogenesis","volume":"479\u2013480","author":"Moss","year":"2015","journal-title":"Virology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1073\/pnas.062163799","article-title":"Complete pathway for protein disulfide bond formation encoded by poxviruses","volume":"99","author":"Senkevich","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Pickup, D.J. (2015). Extracellular Virions: The Advance Guard of Poxvirus Infections. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004904"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1099\/vir.0.030460-0","article-title":"The vaccinia virus A56 protein: A multifunctional transmembrane glycoprotein that anchors two secreted viral proteins","volume":"92","author":"Gupta","year":"2011","journal-title":"J. Gen. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1073\/pnas.95.13.7544","article-title":"Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope","volume":"95","author":"Vanderplasschen","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.virol.2006.08.025","article-title":"Protein composition of the vaccinia virus mature virion","volume":"358","author":"Resch","year":"2007","journal-title":"Virology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1128\/JVI.00011-17","article-title":"Monkeypox Virus Host Factor Screen Using Haploid Cells Identifies Essential Role of GARP Complex in Extracellular Virus Formation","volume":"91","author":"Realegeno","year":"2017","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1128\/JVI.02127-10","article-title":"Capturing the Natural Diversity of the Human Antibody Response against Vaccinia Virus","volume":"85","author":"Lantto","year":"2011","journal-title":"J. Virol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/pmic.200600926","article-title":"Proteome-wide analysis of the serological response to vaccinia and smallpox","volume":"7","author":"Davies","year":"2007","journal-title":"Proteomics"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/JVI.01706-07","article-title":"Antibody Profiling by Proteome Microarray Reveals the Immunogenicity of the Attenuated Smallpox Vaccine Modified Vaccinia Virus Ankara Is Comparable to That of Dryvax","volume":"82","author":"Davies","year":"2008","journal-title":"J. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Senkevich, T.G., Yutin, N., Wolf, Y.I., Koonin, E.V., and Moss, B. (2021). Ancient Gene Capture and Recent Gene Loss Shape the Evolution of Orthopoxvirus-Host Interaction Genes. mBio, 12.","DOI":"10.1128\/mbio.01495-21"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.virol.2005.01.006","article-title":"The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response","volume":"333","author":"Brandt","year":"2005","journal-title":"Virology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.virol.2005.02.014","article-title":"Host range, growth property, and virulence of the smallpox vaccine: Vaccinia virus Tian Tan strain","volume":"335","author":"Fang","year":"2005","journal-title":"Virology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1073\/pnas.1921098117","article-title":"Repair of a previously uncharacterized second host-range gene contributes to full replication of modified vaccinia virus Ankara (MVA) in human cells","volume":"117","author":"Peng","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1016\/j.vaccine.2016.08.002","article-title":"Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators","volume":"34","author":"Sumner","year":"2016","journal-title":"Vaccine"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Hudson, P.N., Self, J., Weiss, S., Braden, Z., Xiao, Y., Girgis, N.M., Emerson, G., Hughes, C., Sammons, S.A., and Isaacs, S.N. (2012). Elucidating the Role of the Complement Control Protein in Monkeypox Pathogenicity. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0035086"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Park, C., Peng, C., Rahman, M.J., Haller, S.L., Tazi, L., Brennan, G., and Rothenburg, S. (2021). Orthopoxvirus K3 orthologs show virus- and host-specific inhibition of the antiviral protein kinase PKR. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009183"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Oliveira, G.P., Rodrigues, R.A.L., Lima, M.T., Drumond, B.P., and Abrah\u00e3o, J.S. (2017). Poxvirus Host Range Genes and Virus-Host Spectrum: A Critical Review. Viruses, 9.","DOI":"10.3390\/v9110331"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.4049\/jimmunol.181.6.4199","article-title":"Smallpox inhibitor of complement enzymes (SPICE): Regulation of complement activation on cells and mechanism of its cellular attachment","volume":"181","author":"Liszewski","year":"2008","journal-title":"J. Immunol."},{"key":"ref_79","unstructured":"(2023, January 02). Smallpox Preparedness Response Updates from FDA, FDA, Available online: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/mcm-issues\/smallpox-preparedness-and-response-updates-fda."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.3390\/v2102381","article-title":"Therapeutic vaccines and antibodies for treatment of orthopoxvirus infections","volume":"2","author":"Xiao","year":"2010","journal-title":"Viruses"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijid.2005.12.001","article-title":"Vaccinia immune globulin: Current policies, preparedness, and product safety and efficacy","volume":"10","author":"Wittek","year":"2006","journal-title":"Int. J. Infect. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.virusres.2007.05.012","article-title":"The identification and characterization of a monoclonal antibody to the vaccinia virus E3 protein","volume":"130","author":"Weaver","year":"2007","journal-title":"Virus Res."},{"key":"ref_83","unstructured":"(2023, March 12). Emergent to Deliver VIGIV to SNS for $535m. Available online: https:\/\/www.biopharma-reporter.com\/Article\/2019\/06\/25\/Emergent-to-deliver-VIGIV-to-SNS-for-535m."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.omtn.2022.05.025","article-title":"Lipid nanoparticle delivery of unmodified mRNAs encoding multiple monoclonal antibodies targeting poxviruses in rabbits","volume":"28","author":"Mucker","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_85","unstructured":"(2023, March 12). DailyMed\u2014CNJ-016 Vaccinia Immune Globulin-Human Injection, Available online: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=a4f9f620-e6e4-4a03-a9a7-79007c8c2cfe."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement","volume":"83","author":"Benhnia","year":"2009","journal-title":"J. Virol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3851\/IMP1573","article-title":"Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model","volume":"15","author":"McCausland","year":"2010","journal-title":"Antivir. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.virol.2018.03.005","article-title":"Characterization of murine antibody responses to vaccinia virus envelope protein A14 reveals an immunodominant antigen lacking of effective neutralization targets","volume":"518","author":"Meng","year":"2018","journal-title":"Virology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1128\/JVI.02878-15","article-title":"Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox","volume":"90","author":"Kaever","year":"2016","journal-title":"J. Virol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"11339","DOI":"10.1128\/JVI.01491-14","article-title":"Potent Neutralization of Vaccinia Virus by Divergent Murine Antibodies Targeting a Common Site of Vulnerability in L1 Protein","volume":"88","author":"Kaever","year":"2014","journal-title":"J. Virol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2011.06.029","article-title":"An epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodies","volume":"418","author":"Xu","year":"2011","journal-title":"Virology"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Gu, X., Zhang, Y., Jiang, W., Wang, D., Lu, J., Gu, G., Qin, C.-F., and Fang, M. (2022). Protective human anti-poxvirus monoclonal antibodies are generated from rare memory B cells isolated by multicolor antigen tetramers. bioRxiv.","DOI":"10.1101\/2022.06.04.494786"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","article-title":"Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections","volume":"167","author":"Gilchuk","year":"2016","journal-title":"Cell"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1128\/JVI.00906-07","article-title":"Characterization of chimpanzee\/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in vitro and in a vaccinia virus mouse protection model","volume":"81","author":"Chen","year":"2007","journal-title":"J. Virol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of Polyclonal or Monoclonal Antibodies to Proteins of the Outer Membranes of the Two Infectious Forms of Vaccinia Virus Protect Mice against a Lethal Respiratory Challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Crickard, L., Babas, T., Seth, S., Silvera, P., Koriazova, L., and Crotty, S. (2012). Protection of Rabbits and Immunodeficient Mice against Lethal Poxvirus Infections by Human Monoclonal Antibodies. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048706"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1038\/s41467-024-48312-2","article-title":"Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections","volume":"15","author":"Zhao","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"7173","DOI":"10.2147\/IJN.S431619","article-title":"Screening, Expression and Identification of Nanobody Against Monkeypox Virus A35R","volume":"18","author":"Meng","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Yu, H., Mao, G., Pei, Z., Cen, J., Meng, W., Wang, Y., Zhang, S., Li, S., Xu, Q., and Sun, M. (2023). In Vitro Affinity Maturation of Nanobodies against Mpox Virus A29 Protein Based on Computer-Aided Design. Molecules, 28.","DOI":"10.3390\/molecules28196838"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1038\/s41467-024-47328-y","article-title":"Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infection","volume":"15","author":"Tamir","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Noy-Porat, T., Tamir, H., Alcalay, R., Rosenfeld, R., Epstein, E., Cherry, L., Achdout, H., Erez, N., Politi, B., and Yahalom-Ronen, Y. (2023). Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralization. Microbiol. Spectr., 11.","DOI":"10.1128\/spectrum.01598-23"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Diesterbeck, U.S., Ahsendorf, H.P., Schirrmann, T., Czerny, C.P., Frenzel, A., and Sharifi, A.R. (2021). Characterization of an in vivo neutralizing anti-vaccinia virus d8 single-chain fragment variable (Scfv) from a human anti-vaccinia virus-specific recombinant library. Vaccines, 9.","DOI":"10.3390\/vaccines9111308"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Matho, M.H., Schlossman, A., Meng, X., Benhnia, M.R.E.I., Kaever, T., Buller, M., Doronin, K., Parker, S., Peters, B., and Crotty, S. (2015). Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005148"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1128\/JVI.01593-09","article-title":"Heavily Isotype-Dependent Protective Activities of Human Antibodies against Vaccinia Virus Extracellular Virion Antigen B5","volume":"83","author":"Benhnia","year":"2009","journal-title":"J. Virol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.virol.2020.02.004","article-title":"Particle-specific neutralizing activity of a monoclonal antibody targeting the poxvirus A33 protein reveals differences between cell associated and extracellular enveloped virions","volume":"544","author":"Mucker","year":"2020","journal-title":"Virology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1073\/pnas.0510598103","article-title":"Chimpanzee\/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus","volume":"103","author":"Chen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Mucker, E.M., Wollen-Roberts, S.E., Kimmel, A., Shamblin, J., Sampey, D., and Hooper, J.W. (2018). Intranasal monkeypox marmoset model: Prophylactic antibody treatment provides benefit against severe monkeypox virus disease. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006581"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"8131","DOI":"10.1128\/JVI.00374-07","article-title":"Major Neutralizing Sites on Vaccinia Virus Glycoprotein B5 Are Exposed Differently on Variola Virus Ortholog B6","volume":"81","author":"Xiao","year":"2007","journal-title":"J. Virol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1128\/JVI.79.10.6260-6271.2005","article-title":"Epitope-Mapping Studies Define Two Major Neutralization Sites on the Vaccinia Virus Extracellular Enveloped Virus Glycoprotein B5R","volume":"79","author":"Whitbeck","year":"2005","journal-title":"J. Virol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/1743-422X-9-217","article-title":"Epitope mapping by random peptide phage display reveals essential residues for vaccinia extracellular enveloped virion spread","volume":"9","author":"He","year":"2012","journal-title":"Virol. J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1128\/jvi.70.6.3753-3762.1996","article-title":"Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene","volume":"70","author":"Roper","year":"1996","journal-title":"J. Virol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A Myristylated Membrane Protein Encoded by the Vaccinia Virus L1R Open Reading Frame Is the Target of Potent Neutralizing Monoclonal Antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.virol.2007.06.042","article-title":"Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein","volume":"368","author":"Su","year":"2007","journal-title":"Virology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1128\/jvi.68.1.130-147.1994","article-title":"Assembly of vaccinia virus: The second wrapping cisterna is derived from the trans Golgi network","volume":"68","author":"Schmelz","year":"1994","journal-title":"J. Virol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Ahsendorf, H., Gan, L., Eltom, K., Abd El Wahed, A., Hotop, S.-K., Roper, R., Beutling, U., Broenstrup, M., Stahl-Hennig, C., and Hoelzle, L. (2019). Species-Specific Conservation of Linear Antigenic Sites on Vaccinia Virus A27 Protein Homologs of Orthopoxviruses. Viruses, 11.","DOI":"10.3390\/v11060493"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1099\/0022-1317-71-10-2341","article-title":"Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies","volume":"71","author":"Czerny","year":"1990","journal-title":"J. Gen. Virol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1099\/0022-1317-83-5-1059","article-title":"Administration to mice of a monoclonal antibody that neutralizes the intracellular mature virus form of vaccinia virus limits virus replication efficiently under prophylactic and therapeutic conditions","volume":"83","author":"Tapia","year":"2002","journal-title":"J. Gen. Virol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/jvi.56.2.482-488.1985","article-title":"Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus","volume":"56","author":"Rodriguez","year":"1985","journal-title":"J. Virol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox vaccines: Targets of protective immunity","volume":"239","author":"Moss","year":"2011","journal-title":"Immunol. Rev."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"Midgley","year":"2006","journal-title":"Nat. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2008.08.009","article-title":"Vaccinia virus entry\/fusion complex subunit A28 is a target of neutralizing and protective antibodies","volume":"380","author":"Nelson","year":"2008","journal-title":"Virology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.virol.2010.05.025","article-title":"The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 protein","volume":"405","author":"Shinoda","year":"2010","journal-title":"Virology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1099\/vir.0.008474-0","article-title":"Smallpox vaccines induce antibodies to the immunomodulatory, secreted vaccinia virus complement control protein","volume":"90","author":"Adamo","year":"2009","journal-title":"J. Gen. Virol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1096\/fj.09-144733","article-title":"The highly virulent variola and monkeypox viruses express secreted inhibitors of type I interferon","volume":"24","author":"Alejo","year":"2010","journal-title":"FASEB J."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Xu, R.-H., Rubio, D., Roscoe, F., Krouse, T.E., Truckenmiller, M.E., Norbury, C.C., Hudson, P.N., Damon, I.K., Alcam\u00ed, A., and Sigal, L.J. (2012). Antibody Inhibition of a Viral Type 1 Interferon Decoy Receptor Cures a Viral Disease by Restoring Interferon Signaling in the Liver. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002475"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1128\/JVI.77.15.8256-8262.2003","article-title":"Restoration of Complement-Enhanced Neutralization of Vaccinia Virus Virions by Novel Monoclonal Antibodies Raised against the Vaccinia Virus Complement Control Protein","volume":"77","author":"Isaacs","year":"2003","journal-title":"J. Virol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virol.2008.04.003","article-title":"Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine","volume":"377","author":"Golden","year":"2008","journal-title":"Virology"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1006\/viro.1994.1240","article-title":"Epitope Detection in the Envelope of Intracellular Naked Orthopox Viruses and Identification of Encoding Genes","volume":"200","author":"Czerny","year":"1994","journal-title":"Virology"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1128\/JVI.00568-08","article-title":"Disparity between Levels of In Vitro Neutralization of Vaccinia Virus by Antibody to the A27 Protein and Protection of Mice against Intranasal Challenge","volume":"82","author":"Fogg","year":"2008","journal-title":"J. Virol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-022-02090-w","article-title":"Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals","volume":"29","author":"Zaeck","year":"2022","journal-title":"Nat. Med."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Reeman, S., Gates, A.J., Pulford, D.J., Krieg, A., and Ulaeto, D.O. (2017). Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant. Viruses, 9.","DOI":"10.3390\/v9120378"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.virol.2007.09.029","article-title":"Immunogenicity and Protection Efficacy of Subunit-based Smallpox Vaccines Using Variola Major Antigens","volume":"371","author":"Sakhatskyy","year":"2008","journal-title":"Virology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit recombinant vaccine protects against monkeypox","volume":"177","author":"Heraud","year":"2006","journal-title":"J. Immunol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1016\/j.vaccine.2020.07.018","article-title":"Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus","volume":"38","author":"Xiao","year":"2020","journal-title":"Vaccine"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Cohen, M.E., Xiao, Y., Eisenberg, R.J., Cohen, G.H., and Isaacs, S.N. (2011). Antibody against extracellular vaccinia virus (ev) protects mice through complement and fc receptors. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0020597"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Moulton, E.A., Atkinson, J.P., and Buller, R.M.L. (2008). Surviving Mousepox Infection Requires the Complement System. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.1000249"},{"key":"ref_138","first-page":"40","article-title":"Non-Human Primate Models of Orthopoxvirus Infections","volume":"1","author":"Schmitt","year":"2014","journal-title":"Vet. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"105702","DOI":"10.1016\/j.isci.2022.105702","article-title":"In vitro and in vivo models for monkeypox","volume":"26","author":"Rosa","year":"2023","journal-title":"iScience"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41577-022-00775-4","article-title":"Monkeypox: Disease epidemiology, host immunity and clinical interventions","volume":"22","author":"Lum","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"109364","DOI":"10.1016\/j.intimp.2022.109364","article-title":"Poxviruses and the immune system: Implications for monkeypox virus","volume":"113","author":"Saghazadeh","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Saied, A.R.A., Dhawan, M., Metwally, A.A., Fahrni, M.L., Choudhary, P., and Choudhary, O.P. (2022). Disease History, Pathogenesis, Diagnostics, and Therapeutics for Human Monkeypox Disease: A Comprehensive Review. Vaccines, 10.","DOI":"10.3390\/vaccines10122091"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/labinvest.3780373","article-title":"The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis)","volume":"81","author":"Zaucha","year":"2001","journal-title":"Lab. Investig."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jcpa.2012.06.007","article-title":"Comparative Pathology of Smallpox and Monkeypox in Man and Macaques","volume":"148","author":"Cann","year":"2013","journal-title":"J. Comp. Pathol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.virol.2010.03.012","article-title":"Dosage comparison of Congo Basin and West African strains of monkeypox virus using a prairie dog animal model of systemic orthopoxvirus disease","volume":"402","author":"Hutson","year":"2010","journal-title":"Virology"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.virol.2014.11.015","article-title":"Comparative live bioluminescence imaging of monkeypox virus dissemination in a wild-derived inbred mouse (Mus musculus castaneus) and outbred African dormouse (Graphiurus kelleni)","volume":"475","author":"Earl","year":"2015","journal-title":"Virology"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"9684","DOI":"10.1016\/j.vaccine.2011.09.135","article-title":"Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques","volume":"29","author":"Denzler","year":"2011","journal-title":"Vaccine"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine\u2013induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Golding","year":"2005","journal-title":"Nat. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"10889","DOI":"10.1073\/pnas.0804985105","article-title":"Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus","volume":"105","author":"Earl","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.virol.2014.11.009","article-title":"Attenuation of monkeypox virus by deletion of genomic regions","volume":"475","author":"Lopera","year":"2015","journal-title":"Virology"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.virol.2015.02.048","article-title":"Genetic studies of the susceptibility of classical and wild-derived inbred mouse strains to monkeypox virus","volume":"481","author":"Earl","year":"2015","journal-title":"Virology"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Earl, P.L., Americo, J.L., and Moss, B. (2020). Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008505"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"M\u00e4tz-Rensing, K., Yue, C., Klenner, J., Ellerbrok, H., and Stahl-Hennig, C. (2017). Limited susceptibility of rhesus macaques to a cowpox virus isolated from a lethal outbreak among New World monkeys. Primate Biol., 4.","DOI":"10.5194\/pb-4-163-2017"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virol.2013.11.017","article-title":"Susceptibility of the wild-derived inbred CAST\/Ei mouse to infection by orthopoxviruses analyzed by live bioluminescence imaging","volume":"449","author":"Americo","year":"2014","journal-title":"Virology"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"524","DOI":"10.7589\/2013-07-171","article-title":"Evaluation of monkeypox virus infection of black-tailed prairie dogs (Cynomys ludovicianus) using in vivo bioluminescent imaging","volume":"50","author":"Falendysz","year":"2014","journal-title":"J. Wildl. Dis."},{"key":"ref_156","first-page":"1128","article-title":"Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model","volume":"6","author":"Hutson","year":"2021","journal-title":"mSphere"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1002\/jcp.26022","article-title":"Humanized mice: A brief overview on their diverse applications in biomedical research","volume":"233","author":"Fujiwara","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Hutson, C.L., Kondas, A.V., Ritter, J.M., Reed, Z., Ostergaard, S.D., Morgan, C.N., Gallardo-Romero, N., Tansey, C., Mauldin, M.R., and Salzer, J.S. (2021). Teaching a new mouse old tricks: Humanized mice as an infection model for Variola virus. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009633"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"197772","DOI":"10.1016\/j.virusres.2019.197772","article-title":"Use of live Variola virus to determine whether CAST\/EiJ mice are a suitable surrogate animal model for human smallpox","volume":"275","author":"Hutson","year":"2020","journal-title":"Virus Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1099\/vir.0.000216","article-title":"Using ICR and SCID mice as animal models for smallpox to assess antiviral drug efficacy","volume":"96","author":"Titova","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Wahl-Jensen, V., Cann, J.A., Rubins, K.H., Huggins, J.W., Fisher, R.W., Johnson, A.J., de Kok-Mercado, F., Larsen, T., Raymond, J.L., and Hensley, L.E. (2011). Progression of Pathogenic Events in Cynomolgus Macaques Infected with Variola Virus. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024832"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1128\/AAC.00977-13","article-title":"Efficacy of Tecovirimat (ST-246) in Nonhuman Primates Infected with Variola Virus (Smallpox)","volume":"57","author":"Mucker","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1073\/pnas.0405954101","article-title":"From the Cover: Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox","volume":"101","author":"Jahrling","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4468\/14\/1\/20\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:42:38Z","timestamp":1760028158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4468\/14\/1\/20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":163,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["antib14010020"],"URL":"https:\/\/doi.org\/10.3390\/antib14010020","relation":{},"ISSN":["2073-4468"],"issn-type":[{"value":"2073-4468","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}